US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kurv Yield Premium Strategy Tesla (TSLA) ETF

20.32

+0.23001.14%

Pre-market: 19.88-0.4400-2.17%08:00 EDT

Volume:18.13K

Turnover:367.81K

Market Cap:22.96M

PE:- -

High:20.35

Open:20.22

Low:20.21

Close:20.09

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)

Upstream Bio announces presentation of data on verekitug’s TSLP receptor

Press Release: Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results

AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TSLP"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TSLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TSLP\",,,,,undefined,":{"symbol":"TSLP","market":"US","secType":"STK","nameCN":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","latestPrice":20.32,"timestamp":1752868800000,"preClose":20.09,"halted":0,"volume":18126,"hourTrading":{"tag":"盘前","latestPrice":19.88,"preClose":20.32,"latestTime":"08:00 EDT","volume":4,"amount":80.63,"timestamp":1753099211471},"delay":0,"floatShares":1130000,"shares":1130000,"eps":0,"marketStatus":"Pre-Mkt","change":0.23,"latestTime":"07-21 08:37:38 EDT","open":20.22,"high":20.35,"low":20.205,"amount":367812.13344,"amplitude":0.007218,"askPrice":26.05,"askSize":100,"bidPrice":18.19,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1753104600000},"marketStatusCode":1,"adr":0,"exchange":"AMEX","adjPreClose":20.32,"sharesOutstanding":1130000,"nav":20.03,"aum":22633900,"dividendRate":0.440945,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":19.88,"preClose":20.32,"latestTime":"08:00 EDT","volume":4,"amount":80.63,"timestamp":1753099211471},"postHourTrading":{"tag":"盘后","latestPrice":20.32,"preClose":20.32,"latestTime":"17:49 EDT","volume":58,"amount":1176.04,"timestamp":1752875381385},"volumeRatio":0.5370708357969054,"impliedVol":0.3678,"impliedVolPercentile":0.6747},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TSLP\",,,,,undefined,":{"symbol":"TSLP","floatShares":1130000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5370708357969054,"shares":1130000,"dividePrice":8.96,"high":20.35,"amplitude":0.007218,"preClose":20.09,"low":20.205,"week52Low":15.36,"pbRate":"--","week52High":34.2895,"institutionHeld":0,"latestPrice":20.32,"eps":0,"divideRate":0.440945,"volume":18126,"delay":0,"ttmEps":0,"open":20.22,"prevYearClose":30.27,"prevWeekClose":20.32,"prevMonthClose":20.31,"prevQuarterClose":20.31,"fiveDayClose":19.65,"twentyDayClose":20.4939,"sixtyDayClose":16.74},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TSLP\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TSLP\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2549549905","title":"Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2549549905","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549549905?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:00","pubTimestamp":1751972400,"startTime":"0","endTime":"0","summary":"– Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in moderate-to-severe COPD – – Broadens global development program for vere","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/08/3111591/0/en/Upstream-Bio-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-Verekitug-in-Chronic-Obstructive-Pulmonary-Disease-COPD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLP"],"gpt_icon":1},{"id":"2543617943","title":"Upstream Bio announces presentation of data on verekitug’s TSLP receptor","url":"https://stock-news.laohu8.com/highlight/detail?id=2543617943","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543617943?lang=en_us&edition=fundamental","pubTime":"2025-06-16 08:30","pubTimestamp":1750033816,"startTime":"0","endTime":"0","summary":"Upstream Bio (UPB) announced the presentation of translational pharmacology modeling data supporting verekitug’s Thymic Stromal Lymphopoietin, TSLP...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/upstream-bio-announces-presentation-of-data-on-verekitugs-tslp-receptor-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/upstream-bio-announces-presentation-of-data-on-verekitugs-tslp-receptor-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UPB","TSLP","BK4139"],"gpt_icon":0},{"id":"2534241948","title":"Press Release: Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2534241948","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534241948?lang=en_us&edition=fundamental","pubTime":"2025-05-12 18:05","pubTimestamp":1747044300,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results. Phase 2 APEX trial of APG777 in atopic dermatitis advancing with interim Part A 16-week data expected in mid-2025 and Part B actively enrolling. First patient dosed in Phase 1b trial of APG777 in mild-to-moderate asthma with readout expected in 1H 2026. APG279 on track to initiate Phase 1b head-to-head trial vs DUPIXENT in 2025 with readout expected in 2H 2026. Positive interim Phase 1b readout of APG808 in patients with mild-to-moderate asthma demonstrated rapid, robust and sustained suppression of FeNO, a biomarker of Type 2 inflammation that is associated with exacerbations in asthma. $681.4 million cash, cash equivalents and marketable securities supports runway into Q1 2028. Apogee conducted third-party quantitative market research in April","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065732104.USD","BK4218","APGE","PK","TSLP","BK4097","PRGS","BK4181","BK4139"],"gpt_icon":0},{"id":"2532683802","title":"AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS","url":"https://stock-news.laohu8.com/highlight/detail?id=2532683802","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532683802?lang=en_us&edition=fundamental","pubTime":"2025-05-02 04:01","pubTimestamp":1746129660,"startTime":"0","endTime":"0","summary":"THOUSAND OAKS, Calif., May 1, 2025 /PRNewswire/ -- Amgen  today announced financial results for the first quarter of 2025.\"Demand for our products was strong globally in the first quarter. Ongoing new product launches and successful Phase 3 trial results for several products make us feel confident in our long-term growth prospects,\" said Robert A. Bradway, chairman and chief executive officer.For the first quarter, total revenues increased 9% to $8.1 billion in comparison to the first quarter of 2024.Product sales grew 11%, primarily driven by 14% volume growth, partially offset by 6% lower net selling price. U.S. sales grew 14%.Fourteen products delivered at least double-digit sales growth in the first quarter, includingRepatha , BLINCYTO , TEZSPIRE , EVENITY , TAVNEOS  and UPLIZNA .Non-GAAP EPS increased 24% from $3.96 to $4.90, driven by higher revenues, partially offset by higher operating expenses.Repatha  sales increased 27% year-over-year to $656 million in the first quarter, pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/amgen-reports-first-quarter-2025-200100246.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-reports-first-quarter-2025-200100246.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4205","IE00BFTCPJ56.SGD","LU1023059063.AUD","BK4566","IE00B2B36J28.USD","TCS","BK4200","LU1057294990.SGD","MPA","IE0009355771.USD","GIPR","LU0889565916.HKD","PN","LU2242646821.SGD","IE0002141913.USD","BK4096","LU0868494617.USD","BK4581","BK4139","BK4188","LU0320765992.SGD","MTA","LU2468319806.SGD","TCI","BK4534","LU2112291526.USD","BK4585","SLE","BK4160","BK4533","LU1983299246.USD","BK4233","BK4077","LU2242652126.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","AMGN","IE00B4R5TH58.HKD","FCF","LU0058720904.USD","LU1061106388.HKD","BK4599","BK4588","LU0122379950.USD","SG9999001440.SGD","BK4211","LU0109394709.USD","TSLP","LU2089984988.USD"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TSLP\",params:#limit:5,,,undefined,":[{"date":"2025-07-02","symbol":"TSLP","amount":0.45,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-02","defaultRemindTime":1751463000000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-03","payableDate":"2025-07-02","currency":"USD","dateTimestamp":1751428800000,"payDate":"2025-07-03"},{"date":"2025-06-04","symbol":"TSLP","amount":0.5,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-04","defaultRemindTime":1749043800000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-05","payableDate":"2025-06-04","currency":"USD","dateTimestamp":1749009600000,"payDate":"2025-06-05"},{"date":"2025-05-07","symbol":"TSLP","amount":0.55,"announcedDate":"2025-05-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-07","defaultRemindTime":1746624600000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-08","payableDate":"2025-05-07","currency":"USD","dateTimestamp":1746590400000,"payDate":"2025-05-08"},{"date":"2025-04-02","symbol":"TSLP","amount":0.55,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-02","defaultRemindTime":1743600600000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-03","payableDate":"2025-04-02","currency":"USD","dateTimestamp":1743566400000,"payDate":"2025-04-03"},{"date":"2025-03-05","symbol":"TSLP","amount":0.7,"announcedDate":"2025-03-04","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-05","defaultRemindTime":1741185000000,"name":"Kurv Yield Premium Strategy Tesla (TSLA) ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-06","payableDate":"2025-03-05","currency":"USD","dateTimestamp":1741150800000,"payDate":"2025-03-06"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TSLP\",market:\"US\",,,undefined,":[{"executeDate":"2023-11-22","recordDate":"2023-11-24","paymentDate":"2023-11-27","value":0.5775,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-22","value":0.6664,"currency":"USD"},{"executeDate":"2024-01-24","recordDate":"2024-01-25","paymentDate":"2024-01-26","value":0.5555,"currency":"USD"},{"executeDate":"2024-02-21","recordDate":"2024-02-22","paymentDate":"2024-02-23","value":0.313,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-22","value":0.5189,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TSLP\",market:\"US\",delay:false,,,undefined,":{}}}